Fine Organic Industries Sets Q2 FY27 Results Review for Nov 2

Fine Organic Industries Limited is scheduled to consider its Q2 FY27 financial results on November 2, 2026, after reporting Q1 sales of ₹6.94 billion and net profit of ₹1.38 billion, each up 18.0% year on year. The meeting will also review the company’s half-year results ended September 30, 2026.

When will Fine Organic Industries announce Q2 FY27 results?

Fine Organic Industries is scheduled to consider and approve unaudited standalone and consolidated results for Q2 FY27 and the first half of FY27 at its board meeting on November 2, 2026. The company informed BSE Limited and the National Stock Exchange of India Limited about the planned meeting through a board-meeting intimation.

The reporting period covers July to September 2026, with the half-year period ending September 30, 2026. At the time of the announcement, Q2 figures had not been filed. Therefore, the board meeting date should not be treated as confirmation of the financial outcome or the timing of the exchange filing after the meeting.

The company had also closed its trading window from October 1, 2026. Its October 22 communication stated that the window would remain closed until November 4, following the planned consideration of the Q2 and half-year results.

What did Fine Organic Industries report in Q1 FY27?

Fine Organic Industries reported sales of ₹6.94 billion for the quarter ended June 2026, compared with ₹5.88 billion in the corresponding quarter a year earlier. This represented year-on-year growth of 18.0%, according to the reported quarterly figures.

Net profit rose 18.0% to ₹1.38 billion in the June 2026 quarter from ₹1.17 billion in the June 2025 quarter. The available company data also listed gross profit of ₹1.62 billion for the quarter, while revenue was stated at ₹6.94 billion.

The June-quarter performance provides the latest reported base before the September-quarter announcement. However, Q1 results do not establish Q2 performance, as the September-quarter financial statements had not been released in the supplied information.

What is the comparison base for the September quarter?

Fine Organic Industries will be measured against a reported Q2 FY26 base of ₹5.97 billion in revenue and ₹1.09 billion in profit for the quarter ended September 2025. These figures provide the direct year-on-year reference point for investors assessing the forthcoming September 2026 numbers.

The September 2025 base followed a June 2025 quarter in which the company reported sales of ₹5.59 billion in the quarterly data series. The historical figures show that quarterly sales have varied across periods, making the official Q2 FY27 filing important for a like-for-like comparison.

Indian listing rules require September-quarter results to be published within 45 days from the end of the quarter. The cited outer deadline for the September 2026 quarter was November 14, 2026. Fine Organic Industries’ November 2 board meeting was therefore scheduled ahead of that deadline.

How have FY27 estimates changed for Fine Organic Industries?

The FY27 consensus revenue forecast for Fine Organic Industries has increased to ₹26.4 billion from ₹25.3 billion. The consensus earnings-per-share estimate has also risen to ₹153 from ₹136 per share, according to the provided forecast data.

The same data set projected FY27 net income of ₹4.68 billion. It indicated expected net-income growth of 7.3% for the next year, compared with a 19% growth forecast for India’s chemicals industry. These are analyst forecasts rather than reported company results.

Forecast revisions indicate that published estimates have moved higher, but the company’s Q2 results will provide the next disclosed financial reference point. Investors will be able to compare reported sales, profitability and any company commentary with the revised FY27 expectations once the filing is available.

Why does the Q2 FY27 update matter to investors?

Fine Organic Industries’ Q2 update matters because it will show whether the sales and profit growth reported in Q1 continued into the September quarter. The company’s ₹6.94 billion Q1 sales and ₹1.38 billion profit set the immediate reported benchmark, while the September 2025 quarter provides the year-on-year base.

The results will also cover the first half of FY27, giving investors a clearer view of performance over six months rather than a single quarter. The unaudited standalone and consolidated statements are expected to provide the formal basis for evaluating revenue, profit and other financial line items for the period.

No Q2 revenue or profit estimate was provided in the source material. As a result, any assessment before the filing should remain limited to reported historical numbers, the board schedule and the disclosed annual consensus forecasts.

Conclusion

Fine Organic Industries’ November 2 board meeting is the scheduled event for considering Q2 FY27 and half-year results, not a confirmed disclosure of the quarter’s financial figures. The company enters the update after Q1 sales and net profit each rose 18.0% year on year, while FY27 revenue and EPS forecasts have been revised upward.

The next item to watch is the exchange filing of unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Investors can compare the reported Q2 outcome with the September 2025 base of ₹5.97 billion in revenue and ₹1.09 billion in profit, as well as the FY27 revenue forecast of ₹26.4 billion.